The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Orphan drugs and rare diseases: a scientometric review (2000 – 2014)
Abstract
Introduction: The literature of orphan drugs and rare diseases between 2000 and 2014 is reviewed. The overall structure of its intellectual landscape is characterized in terms of thematic concentrations of co-cited references and emerging trends of surging keywords and citations to references through a scientometric review – a quantitative study of scientific literature.Areas covered: The review is based on two sets of bibliographic records retrieved from the Web of Science. The core dataset, consisting of 9461 original research articles and review papers, was constructed from a topic search. The expanded dataset, consisting of 82,765 articles and reviews, was constructed by citation expansion.Expert opinion: The study has revealed three broad categories of research. The research policy category focuses on the strategic and integral role of the study of orphan drugs and rare diseases in a wide-ranging societal context, including optimizing the allocation of resources and setting appropriate evaluation standards. The basic research category focuses on understanding the complex biological and genetic mechanisms of rare diseases. The disease-specific research category focuses on specific rare diseases with clinical and therapeutic goals. The study has revealed the fundamental role of genetic variation in linking a diverse range of rare and complex phenotypic patterns. The field would benefit from more comprehensive reviews of all three categories as a whole and disseminating findings and technical advances across various specialties. Finally, building stronger connections between the study of rare diseases and the study of more common diseases is recommended for all three categories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Citation Indexes for Science: A New Dimension in Documentation through Association of Ideas
Garfield, E. (1955) · Science · doi:10.1126/science.122.3159.108 · Cited by 2,334
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786
Clinical research for rare disease: Opportunities, challenges, and solutions
Griggs, R. C., Batshaw, M., Dunkle, M., Gopal-Srivastava, R., Kaye, E., Krischer, J., Nguyen, T., Paulus, K., & Merkel, P. A. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.10.003 · Cited by 401 · cited 1×
“in 2009 [20], which is again from cluster #0 orphan drug.”
Background
Cited by
Climate change and tourism: a scientometric analysis using CiteSpace
Fang, Y., Yin, J., & Wu, B. (2018) · Journal of Sustainable Tourism · doi:10.1080/09669582.2017.1329310 · Cited by 405
Bibliometric visualisation: an application in tourism crisis and disaster management research
Jiang, Y., Ritchie, B. W., & Benckendorff, P. (2019) · Current Issues in Tourism · doi:10.1080/13683500.2017.1408574 · Cited by 353
Mapping the knowledge domains of Building Information Modeling (BIM): A bibliometric approach
Li, X., Wu, P., Shen, G. Q., Wang, X., & Teng, Y. (2017) · Automation in Construction · doi:10.1016/j.autcon.2017.09.011 · Cited by 307
Global trends and future prospects of e-waste research: a bibliometric analysis
Gao, Y., Ge, L., Shi, S., Sun, Y., Liu, M., Wang, B., Shang, Y., Wu, J., & Tian, J. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05071-8 · Cited by 205
Metadata
- Authors
- Chen, C., Dubin, R., & Kim, M. C.
- Venue
- Expert Opinion on Orphan Drugs
- Publisher
- Informa Healthcare
- Published
- 2014-05-28
- Volume
- 2
- Issue
- 7
- Pages
- 709-724
- ISSN
- 2167-8707 (ISSN-L)
- OpenAlex
- W2098373147
- Cited by
- 212
- References
- 8
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Orphan drugs and rare diseases: a scientometric review (2000 – 2014). https://app.cochat.ai/papers/10.1517/21678707.2014.920251
- The paper
- Chen, C., Dubin, R., & Kim, M. C. (2014). Orphan drugs and rare diseases: a scientometric review (2000 – 2014). Expert Opinion on Orphan Drugs. https://doi.org/10.1517/21678707.2014.920251
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.